Swart, Amanda C.
du Toit, Therina
Gourgari, Evgenia
Kidd, Martin
Keil, Meg
Faucz, Fabio R.
Stratakis, Constantine A.
Article History
Received: 17 April 2019
Revised: 7 January 2020
Accepted: 11 March 2020
First Online: 4 April 2020
Competing interests
: C.A.S. holds patent on the <i>PRKAR1A</i>, <i>PDE11A</i>, and <i>GPR101</i> genes and/or their function and his laboratory has received research funding from Pfizer Inc. F.R.F. holds patent on the <i>GPR101</i> gene and/or its function. The other authors have nothing to disclose.
: Informed consent was obtained from all HVs and adult patients; the patients’ parents for all pediatric patients and older children signed an assent.